Skip to content

Global Blood Therapeutics, Inc.

Delisted

CIK 1629137fmd_07J4Z43RZYAVFBQPSYD5PBQ27BManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Jun 30, 2022, 35 periods

Latest annual · FY2021

Millions
Total revenues
195
Gross profit
191
Operating income
(288)
Net income
(303)
Free cash flow
(260)

Latest quarter · Q2 FY2022

Millions
Total revenues
72
Gross profit
70
Operating income
(76)
Net income
(82)
Free cash flow
(45)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
n/m
Revenue, 5 yearsFY2016 to FY2021
n/m
Net income, 5 yearsFY2016 to FY2021
n/m

Global Blood Therapeutics, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$194.7 million$123.8 million+57.3%10-K 2022-02-23 · proof
Gross profit$191.4 million$121.8 million+57.1%10-K 2022-02-23 · proof
Operating income-$287.7 million-$243.2 million10-K 2022-02-23 · proof
Net income-$303.1 million-$247.6 million10-K 2022-02-23 · proof
Cash from operating activities-$256.8 million-$211.9 million10-K 2022-02-23 · proof
Free cash flow-$260 million-$220.6 million10-K 2022-02-23 · proof
Total assets$939.2 million$724 million+29.7%10-K 2022-02-23 · proof
Total liabilities$742.8 million$307.8 million+141.3%10-K 2022-02-23 · proof
Cash and cash equivalents$684.7 million$494.8 million+38.4%10-K 2022-02-23 · proof
What was Global Blood Therapeutics, Inc.'s revenue in fiscal 2021?
Global Blood Therapeutics, Inc. reported revenue of $194.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $123.8 million the year before (+57.3%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was Global Blood Therapeutics, Inc.'s gross profit in fiscal 2021?
Global Blood Therapeutics, Inc. reported gross profit of $191.4 million for fiscal 2021 (the year ended Dec 31, 2021), against $121.8 million the year before (+57.1%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was Global Blood Therapeutics, Inc.'s operating income in fiscal 2021?
Global Blood Therapeutics, Inc. reported operating income of -$287.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$243.2 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was Global Blood Therapeutics, Inc.'s net income in fiscal 2021?
Global Blood Therapeutics, Inc. reported net income of -$303.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$247.6 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was Global Blood Therapeutics, Inc.'s cash from operating activities in fiscal 2021?
Global Blood Therapeutics, Inc. reported cash from operating activities of -$256.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$211.9 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What was Global Blood Therapeutics, Inc.'s free cash flow in fiscal 2021?
Global Blood Therapeutics, Inc. reported free cash flow of -$260 million for fiscal 2021 (the year ended Dec 31, 2021), against -$220.6 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are Global Blood Therapeutics, Inc.'s total assets?
As of Dec 31, 2021, Global Blood Therapeutics, Inc. reported total assets of $939.2 million, against $724 million a year earlier (+29.7%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are Global Blood Therapeutics, Inc.'s total liabilities?
As of Dec 31, 2021, Global Blood Therapeutics, Inc. reported total liabilities of $742.8 million, against $307.8 million a year earlier (+141.3%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC
What are Global Blood Therapeutics, Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Global Blood Therapeutics, Inc. reported cash and cash equivalents of $684.7 million, against $494.8 million a year earlier (+38.4%). Source: the 10-K filed with the SEC on Feb 23, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1629137&period_type=annual&limit=5"

Information only, not investment advice.